US 11,839,636 B1
Pharmaceutical composition based on plant raw materials: #2.1
Babry Oren, Van Nuys, CA (US); and Sasha Moshe, Alpharetta, GA (US)
Filed by Babry Oren, Van Nuys, CA (US); and Sasha Moshe, Alpharetta, GA (US)
Filed on Jul. 27, 2022, as Appl. No. 17/815,548.
Int. Cl. A61K 36/15 (2006.01); A61K 36/87 (2006.01); A61K 36/906 (2006.01); A61K 9/00 (2006.01); A61K 36/31 (2006.01); A61K 36/67 (2006.01); A61K 36/82 (2006.01)
CPC A61K 36/15 (2013.01) [A61K 9/0056 (2013.01); A61K 36/31 (2013.01); A61K 36/67 (2013.01); A61K 36/82 (2013.01); A61K 36/87 (2013.01); A61K 36/906 (2013.01)] 4 Claims
 
1. A medicament composition based on plant raw materials, the composition comprising by weight percent (wt %) thereof:
(a) 12-52 wt % dry powder of pine needles and dry peels and pits of grapes extract and pharmaceutically acceptable additive;
(b) 15-52 wt % dry extract of Rhodiola rosea;
(c) 18-49 wt % dry extract of peony;
(d) 1.2-5 wt % dry extract of green tea;
(e) 4.5-19 wt % dry extract of Ginkgo biloba;
(f) 2-14 wt % dry extract of valerian roots;
(g) 0.5-7.6 wt % of a combination of dry powder of pomegranate juice and dry extract of pomegranate bark; and
(h) 0.1-2 wt % folic acid.